PharmaBiome AG

PharmaBiome AG is at the forefront of biotechnology research, pioneering the development of microbiome-based therapies. Using proprietary tools for the design and production of live biotherapeutic products, PharmaBiome is dedicated to addressing disturbances of the gut microbiome. Located at Schmelzbergstrasse in Zürich, PharmaBiome leverages its first-in-the-industry, patent-protected technology platform to create standardized microbiome-based products.

PharmaBiome is committed to developing the biotechnology necessary to produce solutions compatible with the safety, efficiency, and trial requirements of human medicine. This approach holds the potential for creating personalized treatments for patients with chronic inflammatory diseases, immune conditions, and special nutritional needs. PharmaBiome's biology-based analysis tools enable the identification and selection of metabolic functions needed to restore the gut microbiome to a balanced state.

PharmaBiome continues to innovate and refine its processes, contributing to advancements in microbiome research and therapeutic applications. We invite the manager of PharmaBiome AG to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.